Stay updated on Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 on the page, signaling a new version of the record. This appears to be an internal update rather than a modification to the study details.
    Difference
    0.1%
    Check dated 2026-07-21T13:23:40.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    A new revision tag v3.6.3 was added and the old v3.6.0 tag was removed, signaling an updated page revision.
    Difference
    0.1%
    Check dated 2026-06-30T01:11:27.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardized the Intervention/Treatment heading while removing the previous Intervention / Treatment label; updated the revision line from v3.5.5 to v3.6.0.
    Difference
    0.6%
    Check dated 2026-06-15T20:47:36.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.4 to v3.5.5, indicating an internal update to the page without changes to study information.
    Difference
    0.1%
    Check dated 2026-06-08T17:13:22.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The revision label on the study page was updated from v3.5.3 to v3.5.4. This represents a minor update to the record and does not modify the trial details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-05-18T13:30:07.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    The page’s footer/version label was updated from Revision: v3.5.2 to Revision: v3.5.3, indicating a minor site release change rather than a content change to the clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-26T15:37:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.